Steven Sourbron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Steven Sourbron has a total of 230 co-authors. Here are the top co-authors by number of shared publications:
- Paul D. Hockings
Antaros Medical AB, Mölndal, Sweden
6 shared publications - Eve S. Shalom
Division of Clinical Medicine, University of Sheffield, Polaris, Claremont Crescent 18, Sheffield S10 2TA, England
5 shared publications - Ebony R. Gunwhy
Division of Clinical Medicine, School of Medicine and Population Health, The University of Sheffield, Sheffield, UK
4 shared publications - Geoffrey J. M. Parker
Quantitative Imaging Group, UCL Hawkes Institute, Department of Medical Physics & Biomedical Engineering University College London London UK
4 shared publications - John Charles Waterton
Bioxydyn Ltd Manchester UK
4 shared publications - Aleksandra Galetin
Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK
3 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (10) , 2983-2992
Cardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study
Aims/hypothesis: The aim of this study was to determine whether cardiac autonomic neuropathy (CAN) is an independent risk factor for kidney function decline in type 1 diabetes mellitus over a 15 year follow-up period. Methods: Eighty seven participants with type 1 diabetes and eGFR >30 ml/min per 1.73 m 2 underwent cardiovascular autonomic reflex testing at baseline. Renal data were retrieved at 4 year intervals over 15 years. Stratification of participants into Kidney Disease: Improving Global Outcomes (KDIGO) chronic kidney disease progression prognostic risk was done by using eGFR and urinary albumin/creatinine ratio (UACR). Longitudinal changes in eGFR and UACR were analysed using linear mixed-effects models with adjustment for potential confounders to determine whether CAN is an independent predictor of eGFR and UACR change over 15 years. Results: At baseline, higher KDIGO risk category was associated with increased severity of CAN ( r =0.38, p p 2 , compared with 3.1 (7.3) and 3.3 (7.4) ml/min per 1.73 m 2 in the early stage and those without CAN ( p =0.004). Mean (SD) increases in UACR were 0.4 (0.9), 11.3 (30.4) and 4 (8.9) mg/mmol for no CAN, early CAN and established CAN ( p =0.03), respectively. After adjusting for potential confounders, baseline CAN was independently associated with both accelerated eGFR decline ( p =0.018) and greater increases in UACR ( p =0.002) over time. Conclusions/interpretation: CAN is an independent predictor of both accelerated eGFR decline and increased albuminuria in type 1 diabetes. The study also explored the relationship between CAN and KDIGO prognostic risk in diabetic kidney disease, demonstrating that increased severity of CAN is associated with higher KDIGO prognostic risk.
- 29 July 2026
- Published by Springer Nature in Diabetologia
- Vol. 69 (10) , 2983-2992
Open AccessCardiac autonomic neuropathy predicts renal decline in type 1 diabetes mellitus: a 15 year follow-up study
Aims/hypothesis: The aim of this study was to determine whether cardiac autonomic neuropathy (CAN) is an independent risk factor for kidney function decline in type 1 diabetes mellitus over a 15 year follow-up period. Methods: Eighty seven participants with type 1 diabetes and eGFR >30 ml/min per 1.73 m 2 underwent cardiovascular autonomic reflex testing at baseline. Renal data were retrieved at 4 year intervals over 15 years. Stratification of participants into Kidney Disease: Improving Global Outcomes (KDIGO) chronic kidney disease progression prognostic risk was done by using eGFR and urinary albumin/creatinine ratio (UACR). Longitudinal changes in eGFR and UACR were analysed using linear mixed-effects models with adjustment for potential confounders to determine whether CAN is an independent predictor of eGFR and UACR change over 15 years. Results: At baseline, higher KDIGO risk category was associated with increased severity of CAN ( r =0.38, p p 2 , compared with 3.1 (7.3) and 3.3 (7.4) ml/min per 1.73 m 2 in the early stage and those without CAN ( p =0.004). Mean (SD) increases in UACR were 0.4 (0.9), 11.3 (30.4) and 4 (8.9) mg/mmol for no CAN, early CAN and established CAN ( p =0.03), respectively. After adjusting for potential confounders, baseline CAN was independently associated with both accelerated eGFR decline ( p =0.018) and greater increases in UACR ( p =0.002) over time. Conclusions/interpretation: CAN is an independent predictor of both accelerated eGFR decline and increased albuminuria in type 1 diabetes. The study also explored the relationship between CAN and KDIGO prognostic risk in diabetic kidney disease, demonstrating that increased severity of CAN is associated with higher KDIGO prognostic risk.
- Open Access
Consensus-based technical recommendations for clinical translation of renal Dynamic Contrast-Enhanced (DCE) MRI
Background: Dynamic contrast-enhanced (DCE) MRI has the potential to be a useful tool for non-invasively assessing renal haemodynamics and function, however insufficient standardisation and difficulties in post-processing remain barriers to clinical translation. Purpose: To develop expert consensus-based technical recommendations for performing renal DCE-MRI in humans, relating to aspects of patient preparation, MRI hardware and acquisition parameters, and data analysis. Study Type: Systematic consensus process using an approximation to the two-step modified Delphi method. Population: Not applicable. Field Strength / Sequence: 1.5 T and 3 T / Renal gradient echo-based 3D DCE-MRI. Assessment: An international panel of experts were recruited and surveyed following a modified Delphi method to create consensus-based technical recommendations. Key areas for consensus were initially identified through a mixture of online and in-person discussions, and an initial survey round consisting of open- and close-ended questions. Consensus statements were formulated and iteratively refined to create the final recommendations. Statistical Tests: Consensus was defined as ≥ 75% agreement in response (excluding abstentions), and clear preference was defined as [60-74]% agreement among the experts. Statements with ≥40% abstentions were either excluded from subsequent survey rounds or recirculated as a modified statement. Results: 22 experts initially participated in the Delphi panel, of which 16 responded to the first survey. 15 panellists responded to all subsequent surveys. Out of 46 statements, 37 reached consensus and one showed clear preference. ≥40% abstention was found in seven statements which were excluded from the final set of recommendations. Data conclusion: These recommendations provide a starting point for MRI centres worldwide wishing to perform renal DCE-MRI, contributing to the harmonisation of DCE-MRI scan protocols and facilitating clinical translation. These recommendations provide a practical minimum technical dataset for renal DCE-MRI acquisition and analysis to improve cross-site comparability and support responsible clinical translation.
Open AccessConsensus-based technical recommendations for clinical translation of renal Dynamic Contrast-Enhanced (DCE) MRI
Background: Dynamic contrast-enhanced (DCE) MRI has the potential to be a useful tool for non-invasively assessing renal haemodynamics and function, however insufficient standardisation and difficulties in post-processing remain barriers to clinical translation. Purpose: To develop expert consensus-based technical recommendations for performing renal DCE-MRI in humans, relating to aspects of patient preparation, MRI hardware and acquisition parameters, and data analysis. Study Type: Systematic consensus process using an approximation to the two-step modified Delphi method. Population: Not applicable. Field Strength / Sequence: 1.5 T and 3 T / Renal gradient echo-based 3D DCE-MRI. Assessment: An international panel of experts were recruited and surveyed following a modified Delphi method to create consensus-based technical recommendations. Key areas for consensus were initially identified through a mixture of online and in-person discussions, and an initial survey round consisting of open- and close-ended questions. Consensus statements were formulated and iteratively refined to create the final recommendations. Statistical Tests: Consensus was defined as ≥ 75% agreement in response (excluding abstentions), and clear preference was defined as [60-74]% agreement among the experts. Statements with ≥40% abstentions were either excluded from subsequent survey rounds or recirculated as a modified statement. Results: 22 experts initially participated in the Delphi panel, of which 16 responded to the first survey. 15 panellists responded to all subsequent surveys. Out of 46 statements, 37 reached consensus and one showed clear preference. ≥40% abstention was found in seven statements which were excluded from the final set of recommendations. Data conclusion: These recommendations provide a starting point for MRI centres worldwide wishing to perform renal DCE-MRI, contributing to the harmonisation of DCE-MRI scan protocols and facilitating clinical translation. These recommendations provide a practical minimum technical dataset for renal DCE-MRI acquisition and analysis to improve cross-site comparability and support responsible clinical translation.
- Open Access
- 11 December 2025
- Published by Frontiers Media SA in Frontiers in Nuclear Medicine
- Vol. 5, 1706155
MR-guided reconstruction of PET data in spinal cord PET/MRI
Introduction: Accurate PET reconstruction in spinal cord PET/MRI is challenging due to the small size of the structure and interference from background activity. The aim of this study was to establish whether MR-guided PET reconstruction can improve the accuracy of measured uptake in the spinal cord. Methods: The hybrid kernel expectation maximisation (HKEM) algorithm was evaluated on a digital anthropomorphic phantom (XNAT), and an implementation of a modified asymmetric Bowsher's prior incorporating both PET and MR data was evaluated on clinical test cases. The methods were compared against commonly used algorithms OSEM and Q.Clear. Results: The results demonstrated that the two algorithms lead to an increase in measured [ 18 F ]FDG PET tracer uptake in the spinal cord. Comparison to ground truth indicates that the improvement is insufficient to remove the bias in this small structure. Discussion: With care taken to optimise for the desired application, novel PET image reconstruction algorithms using PET and MR data to inform iterative image updates lead to improved quantification and improved image quality compared to OSEM. Further work is needed to investigate the optimal parameters and identify strategies to reduce residual bias.
- 11 December 2025
- Published by Frontiers Media SA in Frontiers in Nuclear Medicine
- Vol. 5, 1706155
Open AccessMR-guided reconstruction of PET data in spinal cord PET/MRI
Introduction: Accurate PET reconstruction in spinal cord PET/MRI is challenging due to the small size of the structure and interference from background activity. The aim of this study was to establish whether MR-guided PET reconstruction can improve the accuracy of measured uptake in the spinal cord. Methods: The hybrid kernel expectation maximisation (HKEM) algorithm was evaluated on a digital anthropomorphic phantom (XNAT), and an implementation of a modified asymmetric Bowsher's prior incorporating both PET and MR data was evaluated on clinical test cases. The methods were compared against commonly used algorithms OSEM and Q.Clear. Results: The results demonstrated that the two algorithms lead to an increase in measured [ 18 F ]FDG PET tracer uptake in the spinal cord. Comparison to ground truth indicates that the improvement is insufficient to remove the bias in this small structure. Discussion: With care taken to optimise for the desired application, novel PET image reconstruction algorithms using PET and MR data to inform iterative image updates lead to improved quantification and improved image quality compared to OSEM. Further work is needed to investigate the optimal parameters and identify strategies to reduce residual bias.
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (3) , e251899
Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study
The biliary excretion rate and hepatocellular uptake rate of gadoxetate are promising biomarkers for research into drug-mediated inhibition of hepatocellular transporter function.
- 1 December 2025
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 317 (3) , e251899
Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study
The biliary excretion rate and hepatocellular uptake rate of gadoxetate are promising biomarkers for research into drug-mediated inhibition of hepatocellular transporter function.
- Open Access
- 26 August 2025
- Published by Frontiers Media SA in Frontiers in Nuclear Medicine
- Vol. 5, 1646662
Quantification of FDG in the spinal cord using PET/MRI
Background: In this study, we investigate the impact of MR-derived attenuation maps and limited detector resolution on the quantification of positron emission tomography (PET) activity uptake in the spinal cord during PET/MRI. This was performed by simulating [F]FDG PET data in the neck and thorax and then modifying the attenuation map to remove bone features. We then compared Ordered Subset Expectation Maximisation-reconstructed images to those with full attenuation correction. This simulation was performed at two detector resolutions of 2.1 and 4.4 mm. Acquisitions from a clinical study were then used to assess the ability of point spread function (PSF) modelling and time-of-flight (TOF) corrections, as implemented on the SIGNA PET/MR scanner (GE HealthCare), to correct for these quantification errors. For comparison, mean uptake was measured in regions of interest at each vertebral position along the spinal cord.Results: Simulation results showed a decreasing pattern of uptake from the cervical to the thoracic spinal cord. When bone was not included in attenuation correction, the mean uptake decreased by 3%–10.4%. This difference in measured uptake was 6.4%–23.9% in images simulated at a detector resolution representative of a clinical PET/MRI scanner. At a detector resolution of 4.4 mm, a 32.2% decrease in uptake was measured compared to the 2.1 mm simulation. In patient data, introducing vertebral bone to the attenuation correction pseudo-CT led to a 1.8%–18.3% difference in in the spinal cord. Applying PSF modelling did not lead to any statistically significant changes. TOF correction reduces the difference in between data attenuation corrected with and without vertebral bone to 4.3%–7%. TOF Q.Clear images with beta = 100 showed the smallest difference between attenuation correction approaches at 0.6%–5.2%.Conclusion: Ignoring bone during image reconstruction in PET/MRI reduces the activity measured during quantification of the spinal cord; however, the partial volume effect has a greater impact on reducing measured uptake in lower-resolution data. While time-of-flight correction goes somewhat resolves these quantification errors, further research is needed into partial volume correction.- 26 August 2025
- Published by Frontiers Media SA in Frontiers in Nuclear Medicine
- Vol. 5, 1646662
Open AccessQuantification of FDG in the spinal cord using PET/MRI
Background: In this study, we investigate the impact of MR-derived attenuation maps and limited detector resolution on the quantification of positron emission tomography (PET) activity uptake in the spinal cord during PET/MRI. This was performed by simulating [F]FDG PET data in the neck and thorax and then modifying the attenuation map to remove bone features. We then compared Ordered Subset Expectation Maximisation-reconstructed images to those with full attenuation correction. This simulation was performed at two detector resolutions of 2.1 and 4.4 mm. Acquisitions from a clinical study were then used to assess the ability of point spread function (PSF) modelling and time-of-flight (TOF) corrections, as implemented on the SIGNA PET/MR scanner (GE HealthCare), to correct for these quantification errors. For comparison, mean uptake was measured in regions of interest at each vertebral position along the spinal cord.Results: Simulation results showed a decreasing pattern of uptake from the cervical to the thoracic spinal cord. When bone was not included in attenuation correction, the mean uptake decreased by 3%–10.4%. This difference in measured uptake was 6.4%–23.9% in images simulated at a detector resolution representative of a clinical PET/MRI scanner. At a detector resolution of 4.4 mm, a 32.2% decrease in uptake was measured compared to the 2.1 mm simulation. In patient data, introducing vertebral bone to the attenuation correction pseudo-CT led to a 1.8%–18.3% difference in in the spinal cord. Applying PSF modelling did not lead to any statistically significant changes. TOF correction reduces the difference in between data attenuation corrected with and without vertebral bone to 4.3%–7%. TOF Q.Clear images with beta = 100 showed the smallest difference between attenuation correction approaches at 0.6%–5.2%.Conclusion: Ignoring bone during image reconstruction in PET/MRI reduces the activity measured during quantification of the spinal cord; however, the partial volume effect has a greater impact on reducing measured uptake in lower-resolution data. While time-of-flight correction goes somewhat resolves these quantification errors, further research is needed into partial volume correction. - Open Access
Assessing drug-mediated inhibition of liver transporter function with MRI: A first-in-human study
Background: Assessing the risk of drug-mediated liver injury (DILI) and liver-mediated drug-drug interactions (DDI) for new drugs requires biomarkers that respond to drug effects on hepatic transporters. Evidence in rats has shown that dynamic gadoxetate-enhanced MRI (DGE-MRI) is suitable for this purpose, but it is not known whether these findings translate to humans. Purpose: To determine the effects of rifampicin, a known inhibitor of hepatocyte transporters OATP1B and MRP2, on gadoxetate uptake and excretion rates in the liver of healthy volunteers. Materials and Methods: This prospective study recruited 10 healthy volunteers, who were assessed on two separate visits. DGE-MRI was performed over two separate scans, one hour apart, due to the slow hepatic excretion of gadoxetate after inhibition. DGE was acquired with a fast (2.5 sec) 3D free-breathing protocol collecting data continuously for 50 minutes. Gadoxetate was injected at 1/8 th of a clinical dose, escalated to 1/4 th after the first 3 volunteers. On the second visit, rifampicin (600mg) was administered orally one hour before the start of the scan. Liver uptake and excretion rates were derived by modelling signal-time curves in aorta and liver. The effect of rifampicin was determined with a paired t-test with significance level at p<0.01. Results: Eight of the 10 participants (3 female/7 male, mean age 32) completed both visits. Rifampicin reduced hepatocellular uptake rate of gadoxetate by 93% (95%CI 91-95%, p<0.001). Biliary excretion rate was reduced by 50% (p=0.004) but the effect was more variable (95%CI 8- 92%). Both rates were reduced by rifampicin in every participant, except for the excretion rate of one participant who had low baseline levels. Conclusion: MRI measurements of gadoxetate biliary excretion and liver uptake rates can robustly detect inhibition of hepatocellular function mediated via OATP1B and MRP2 transporters.
Open AccessAssessing drug-mediated inhibition of liver transporter function with MRI: A first-in-human study
Background: Assessing the risk of drug-mediated liver injury (DILI) and liver-mediated drug-drug interactions (DDI) for new drugs requires biomarkers that respond to drug effects on hepatic transporters. Evidence in rats has shown that dynamic gadoxetate-enhanced MRI (DGE-MRI) is suitable for this purpose, but it is not known whether these findings translate to humans. Purpose: To determine the effects of rifampicin, a known inhibitor of hepatocyte transporters OATP1B and MRP2, on gadoxetate uptake and excretion rates in the liver of healthy volunteers. Materials and Methods: This prospective study recruited 10 healthy volunteers, who were assessed on two separate visits. DGE-MRI was performed over two separate scans, one hour apart, due to the slow hepatic excretion of gadoxetate after inhibition. DGE was acquired with a fast (2.5 sec) 3D free-breathing protocol collecting data continuously for 50 minutes. Gadoxetate was injected at 1/8 th of a clinical dose, escalated to 1/4 th after the first 3 volunteers. On the second visit, rifampicin (600mg) was administered orally one hour before the start of the scan. Liver uptake and excretion rates were derived by modelling signal-time curves in aorta and liver. The effect of rifampicin was determined with a paired t-test with significance level at p<0.01. Results: Eight of the 10 participants (3 female/7 male, mean age 32) completed both visits. Rifampicin reduced hepatocellular uptake rate of gadoxetate by 93% (95%CI 91-95%, p<0.001). Biliary excretion rate was reduced by 50% (p=0.004) but the effect was more variable (95%CI 8- 92%). Both rates were reduced by rifampicin in every participant, except for the excretion rate of one participant who had low baseline levels. Conclusion: MRI measurements of gadoxetate biliary excretion and liver uptake rates can robustly detect inhibition of hepatocellular function mediated via OATP1B and MRP2 transporters.
- Open Access
- 15 February 2025
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 38 (5) , 791-802
A method to measure renal inner medullary perfusion using MR renography
Objective: In the kidney, the medulla is most susceptible to damage in case of hampered perfusion or oxygenation. Due to separate regulation of cortical and medullary perfusion, measurement of both is crucial to improve the understanding of renal pathophysiology. We aim to develop and evaluate a physiologically accurate model to measure renal inner medullary (Fmed) and cortical perfusion (Fcor) separately. Materials and methods: We developed a 7-compartment model of renal perfusion and used an iterated approach to fit 10 free parameters. Model stability and accuracy were tested on both patient data and simulations. Cortical perfusion and FT (tubular flow or glomerular filtration rate per unit of tissue volume) were compared to a conventional 2-compartment filtration model. Results: Average (standard deviation) Fmed was 37(23)mL/100 mL/min. Fitting stability as expressed by the median (interquartile range) coefficient of variation between fits was 0.0(0.0–5.8)%, with outliers up to 81%. In simulations, Fmed was underestimated by around 8%. Intra-class correlation coefficients for Fcor and FT as measured with the 2- and 7- compartment model were 0.87 and 0.63, respectively. Discussion: We developed a pharmacokinetic model closely following renal physiology. Although the results were vulnerable for overfitting, relatively stable results could be obtained even for Fmed.
- 15 February 2025
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 38 (5) , 791-802
Open AccessA method to measure renal inner medullary perfusion using MR renography
Objective: In the kidney, the medulla is most susceptible to damage in case of hampered perfusion or oxygenation. Due to separate regulation of cortical and medullary perfusion, measurement of both is crucial to improve the understanding of renal pathophysiology. We aim to develop and evaluate a physiologically accurate model to measure renal inner medullary (Fmed) and cortical perfusion (Fcor) separately. Materials and methods: We developed a 7-compartment model of renal perfusion and used an iterated approach to fit 10 free parameters. Model stability and accuracy were tested on both patient data and simulations. Cortical perfusion and FT (tubular flow or glomerular filtration rate per unit of tissue volume) were compared to a conventional 2-compartment filtration model. Results: Average (standard deviation) Fmed was 37(23)mL/100 mL/min. Fitting stability as expressed by the median (interquartile range) coefficient of variation between fits was 0.0(0.0–5.8)%, with outliers up to 81%. In simulations, Fmed was underestimated by around 8%. Intra-class correlation coefficients for Fcor and FT as measured with the 2- and 7- compartment model were 0.87 and 0.63, respectively. Discussion: We developed a pharmacokinetic model closely following renal physiology. Although the results were vulnerable for overfitting, relatively stable results could be obtained even for Fmed.
- Open Access
- 23 May 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (11) , 115034
Identifiability of spatiotemporal tissue perfusion models
Objective. Standard models for perfusion quantification in DCE-MRI produce a bias by treating voxels as isolated systems. Spatiotemporal models can remove this bias, but it is unknown whether they are fundamentally identifiable. The aim of this study is to investigate this question in silico using one-dimensional toy systems with a one-compartment blood flow model and a two-compartment perfusion model. Approach. For each of the two models, identifiability is explored theoretically and in-silico for three systems. Concentrations over space and time are simulated by forward propagation. Different levels of noise and temporal undersampling are added to investigate sensitivity to measurement error. Model parameters are fitted using a standard gradient descent algorithm, applied iteratively with a stepwise increasing time window. Model fitting is repeated with different initial values to probe uniqueness of the solution. Reconstruction accuracy is quantified for each parameter by comparison to the ground truth. Main results. Theoretical analysis shows that flows and volume fractions are only identifiable up to a constant, and that this degeneracy can be removed by proper choice of parameters. Simulations show that in all cases, the tissue concentrations can be reconstructed accurately. The one-compartment model shows accurate reconstruction of blood velocities and arterial input functions, independent of the initial values and robust to measurement error. The two-compartmental perfusion model was not fully identifiable, showing good reconstruction of arterial velocities and input functions, but multiple valid solutions for the perfusion parameters and venous velocities, and a strong sensitivity to measurement error in these parameters. Significance. These results support the use of one-compartment spatiotemporal flow models, but two-compartment perfusion models were not sufficiently identifiable. Future studies should investigate whether this degeneracy is resolved in more realistic 2D and 3D systems, by adding physically justified constraints, or by optimizing experimental parameters such as injection duration or temporal resolution.
- 23 May 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (11) , 115034
Open AccessIdentifiability of spatiotemporal tissue perfusion models
Objective. Standard models for perfusion quantification in DCE-MRI produce a bias by treating voxels as isolated systems. Spatiotemporal models can remove this bias, but it is unknown whether they are fundamentally identifiable. The aim of this study is to investigate this question in silico using one-dimensional toy systems with a one-compartment blood flow model and a two-compartment perfusion model. Approach. For each of the two models, identifiability is explored theoretically and in-silico for three systems. Concentrations over space and time are simulated by forward propagation. Different levels of noise and temporal undersampling are added to investigate sensitivity to measurement error. Model parameters are fitted using a standard gradient descent algorithm, applied iteratively with a stepwise increasing time window. Model fitting is repeated with different initial values to probe uniqueness of the solution. Reconstruction accuracy is quantified for each parameter by comparison to the ground truth. Main results. Theoretical analysis shows that flows and volume fractions are only identifiable up to a constant, and that this degeneracy can be removed by proper choice of parameters. Simulations show that in all cases, the tissue concentrations can be reconstructed accurately. The one-compartment model shows accurate reconstruction of blood velocities and arterial input functions, independent of the initial values and robust to measurement error. The two-compartmental perfusion model was not fully identifiable, showing good reconstruction of arterial velocities and input functions, but multiple valid solutions for the perfusion parameters and venous velocities, and a strong sensitivity to measurement error in these parameters. Significance. These results support the use of one-compartment spatiotemporal flow models, but two-compartment perfusion models were not sufficiently identifiable. Future studies should investigate whether this degeneracy is resolved in more realistic 2D and 3D systems, by adding physically justified constraints, or by optimizing experimental parameters such as injection duration or temporal resolution.
- Open Access
- 21 February 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 60 (5) , 2144-2155
Improvements in Between‐Vendor MRI Harmonization of Renal T2 Mapping using Stimulated Echo Compensation
Background: T2 mapping is valuable to evaluate pathophysiology in kidney disease. However, variations in T2 relaxation time measurements across MR scanners and vendors may occur requiring additional correction.Purpose: To harmonize renal T2 measurements between MR vendor platforms, and use an extended‐phase‐graph‐based fitting method (“StimFit”) to correct stimulated echoes and reduce between‐vendor variations.Study Type: Prospective.Subjects: 8 healthy “travelling” volunteers (37.5% female, 32 ± 6 years) imaged on four MRI systems across three vendors at four sites, 10 healthy volunteers (50% female, 32 ± 8 years) scanned multiple times on a given MR scanner for repeatability evaluation. ISMRM/NIST system phantom scanned for evaluation of T2 accuracy.Field Strength/Sequence: 3T, multiecho spin‐echo sequence.Assessment: T2 images fit using conventional monoexponential fitting and “StimFit.” Mean absolute percentage error (MAPE) of phantom measurements with reference T2 values. Average cortex and medulla T2 values compared between MR vendors, with masks obtained from T2‐weighted images and T1 maps. Full‐width‐at‐half‐maximum (FWHM) T2 distributions to evaluate local homogeneity of measurements.Statistical Tests: Coefficient of variation (CV), linear mixed‐effects model, analysis of variance, student's t‐tests, Bland–Altman plots, P‐value 2 measurements between vendors using a monoexponential fit, but not with “StimFit” (P = 0.86 and 0.92, cortex and medulla, respectively). The intervendor CVs of T2 measures were reduced from 8.0% to 2.6% (cortex) and 7.1% to 2.8% (medulla) with StimFit, resulting in no significant differences for the CVs of intravendor repeat acquisitions (P = 0.13 and 0.05). “StimFit” significantly reduced the FWHM of T2 distributions in the cortex and whole kidney.Data Conclusion: Stimulated‐echo correction reduces renal T2 variation across MR vendor platforms.Level of Evidence: 2Technical Efficacy: Stage 1
- 21 February 2024
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 60 (5) , 2144-2155
Open AccessImprovements in Between‐Vendor MRI Harmonization of Renal T2 Mapping using Stimulated Echo Compensation
Background: T2 mapping is valuable to evaluate pathophysiology in kidney disease. However, variations in T2 relaxation time measurements across MR scanners and vendors may occur requiring additional correction.Purpose: To harmonize renal T2 measurements between MR vendor platforms, and use an extended‐phase‐graph‐based fitting method (“StimFit”) to correct stimulated echoes and reduce between‐vendor variations.Study Type: Prospective.Subjects: 8 healthy “travelling” volunteers (37.5% female, 32 ± 6 years) imaged on four MRI systems across three vendors at four sites, 10 healthy volunteers (50% female, 32 ± 8 years) scanned multiple times on a given MR scanner for repeatability evaluation. ISMRM/NIST system phantom scanned for evaluation of T2 accuracy.Field Strength/Sequence: 3T, multiecho spin‐echo sequence.Assessment: T2 images fit using conventional monoexponential fitting and “StimFit.” Mean absolute percentage error (MAPE) of phantom measurements with reference T2 values. Average cortex and medulla T2 values compared between MR vendors, with masks obtained from T2‐weighted images and T1 maps. Full‐width‐at‐half‐maximum (FWHM) T2 distributions to evaluate local homogeneity of measurements.Statistical Tests: Coefficient of variation (CV), linear mixed‐effects model, analysis of variance, student's t‐tests, Bland–Altman plots, P‐value 2 measurements between vendors using a monoexponential fit, but not with “StimFit” (P = 0.86 and 0.92, cortex and medulla, respectively). The intervendor CVs of T2 measures were reduced from 8.0% to 2.6% (cortex) and 7.1% to 2.8% (medulla) with StimFit, resulting in no significant differences for the CVs of intravendor repeat acquisitions (P = 0.13 and 0.05). “StimFit” significantly reduced the FWHM of T2 distributions in the cortex and whole kidney.Data Conclusion: Stimulated‐echo correction reduces renal T2 variation across MR vendor platforms.Level of Evidence: 2Technical Efficacy: Stage 1
- Open Access
- 19 December 2023
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 91 (5) , 1803-1821
The ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): Results from the OSIPI–Dynamic Contrast‐Enhanced challenge
Purpose: has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging–Dynamic Contrast‐Enhanced (OSIPI‐DCE) challenge was designed to benchmark methods to better help the efforts to standardize measurement.Methods: A framework was created to evaluate values produced by DCE‐MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants' values, the applied software, and a standard operating procedure. These were evaluated using the proposed score defined with accuracy, repeatability, and reproducibility components.Results: Across the 10 received submissions, the score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0–1 = lowest–highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.Conclusions: This study reports results from the OSIPI‐DCE challenge and highlights the high inter‐software variability within estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real‐world clinical setting, many of these tools may perform differently with different benchmarking methodology.
- 19 December 2023
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 91 (5) , 1803-1821
Open AccessThe ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): Results from the OSIPI–Dynamic Contrast‐Enhanced challenge
Purpose: has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging–Dynamic Contrast‐Enhanced (OSIPI‐DCE) challenge was designed to benchmark methods to better help the efforts to standardize measurement.Methods: A framework was created to evaluate values produced by DCE‐MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants' values, the applied software, and a standard operating procedure. These were evaluated using the proposed score defined with accuracy, repeatability, and reproducibility components.Results: Across the 10 received submissions, the score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0–1 = lowest–highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.Conclusions: This study reports results from the OSIPI‐DCE challenge and highlights the high inter‐software variability within estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real‐world clinical setting, many of these tools may perform differently with different benchmarking methodology.